Small study shows convalescent plasma is safe to use in pediatric patients with COVID-19

Philadelphia, September 8, 2020 — Early findings from researchers at Children’s Hospital of Philadelphia (CHOP) show that convalescent plasma appears to be a safe and possibly effective treatment for children with life-threatening cases of COVID-19. The results were published online Friday by the journal Pediatric Blood and Cancer. To date, no therapies have been proven…

Details

Linking calorie restriction, body temperature and healthspan

LA JOLLA, CA—Cutting calories significantly may not be an easy task for most, but it’s tied to a host of health benefits ranging from longer lifespan to a much lower chance of developing cancer, heart disease, diabetes and neurodegenerative conditions such as Alzheimer’s. A new study from teams led by Scripps Research Professors Bruno Conti,…

Details

How birth control, girls’ education can slow population growth

Widespread use of contraceptives and, to a lesser extent, girls’ education through at least age 14 have the greatest impact in bringing down a country’s fertility rate. Education and family planning have long been tied to lower fertility trends. But new research from the University of Washington analyzes those factors to determine, what accelerates a…

Details

OHSU discovers cell in zebrafish critical to brain assembly, function

New research from Oregon Health & Science University for the first time documents the presence of astrocytes in zebrafish, a milestone that will open new avenues of research into a star-shaped type of glial cell in the brain that is critical for nearly every aspect of brain assembly and function. The research was published this…

Details

The ESCMID Conference on Coronavirus Disease (ECCVID)

The ESCMID Conference on Coronavirus Disease (ECCVID) will take place online from Wednesday 23 to Friday 25 September 2020. This will be the first conference focussing exclusively on COVID-19 organised by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). It will cover all aspects of SARS-CoV-2 and COVID-19 disease, featuring a comprehensive scientific…

Details

State laws key to HIV prevention efforts

PHILADELPHIA (September 8, 2020) — HIV prevention remains a public health priority in the United States. Pre-exposure prophylaxis (PrEP) is a drug regimen recommended for individuals who have engaged in behaviors that place them at elevated risk for HIV. When used consistently, daily oral PrEP has been shown to reduce HIV transmission by 99 percent.…

Details

MD Anderson and Astex Pharmaceuticals announce strategic collaboration to accelerate clinical evaluation of therapies for patients with leukemia

The University of Texas MD Anderson Cancer Center and Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co. Ltd., based in Tokyo, Japan, today announce a strategic collaboration agreement aimed at accelerating the clinical evaluation of Astex’s pipeline of products for patients with certain types of leukemia, including myelodysplastic syndromes (MDS), chronic myelomonocytic…

Details